BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29338045)

  • 1. Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein.
    Kim AR; Lee DH; Lee SH; Rubino I; Choi HJ; Quan FS
    PLoS One; 2018; 13(1):e0191277. PubMed ID: 29338045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
    Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
    Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
    Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
    Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    Quan FS; Kim Y; Lee S; Yi H; Kang SM; Bozja J; Moore ML; Compans RW
    J Infect Dis; 2011 Oct; 204(7):987-95. PubMed ID: 21881112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.
    Terhüja M; Siddappa M; Lamichhane P; Meshram CD; Snider TA; Ritchey JW; Oomens AGP
    Viruses; 2024 May; 16(6):. PubMed ID: 38932136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.
    Murawski MR; McGinnes LW; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Heaton PM; Fraire AE; Morrison TG
    J Virol; 2010 Jan; 84(2):1110-23. PubMed ID: 19889768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Lee S; Quan FS; Kwon Y; Sakamoto K; Kang SM; Compans RW; Moore ML
    Antiviral Res; 2014 Nov; 111():129-35. PubMed ID: 25239522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two RSV Platforms for G, F, or G+F Proteins VLPs.
    Ha B; Yang JE; Chen X; Jadhao SJ; Wright ER; Anderson LJ
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32824936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
    McGinnes Cullen L; Luo B; Wen Z; Zhang L; Durr E; Morrison TG
    J Virol; 2023 Jan; 97(1):e0190022. PubMed ID: 36602367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.
    Blanco JCG; Pletneva LM; McGinnes-Cullen L; Otoa RO; Patel MC; Fernando LR; Boukhvalova MS; Morrison TG
    Nat Commun; 2018 May; 9(1):1904. PubMed ID: 29765035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.
    Schmidt MR; McGinnes-Cullen LW; Kenward SA; Willems KN; Woodland RT; Morrison TG
    J Virol; 2014 Sep; 88(17):10165-76. PubMed ID: 24965456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
    Cullen LM; Blanco JC; Morrison TG
    J Transl Med; 2015 Nov; 13():350. PubMed ID: 26541285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.
    McGinnes LW; Gravel KA; Finberg RW; Kurt-Jones EA; Massare MJ; Smith G; Schmidt MR; Morrison TG
    J Virol; 2011 Jan; 85(1):366-77. PubMed ID: 20980510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Lei L; Qin H; Luo J; Tan Y; Yang J; Pan Z
    Virus Res; 2021 Jun; 298():198410. PubMed ID: 33819519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.